Letter from the Director: Syphilis, Treponema, and Reverse Algorithm Testing
Syphilis is a systemic sexually transmitted infection caused by the bacterium Treponema pallidum. The disease can be transmitted through sexual contact (person to person) or vertically from an infected mother to her unborn child. Despite reaching its lowest rate
Letter from the Director: Understanding the Benefit of the CKD-EPI 2021 Formula in eGFR Reporting
The production of urine and the removal of waste products from the body is based on filtering blood through the glomerular membrane in the kidneys. The best assessment to measure how much blood the kidneys filter each minute is
Letter from the Director: QuantiFERON-TB Gold Plus testing offers accuracy in health monitoring for patients
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb). A person infected with MTB might end up with TB disease with clinical, radiographic, and microbiological evidence of tuberculosis, or will have no clinical evidence of TB disease and
Letter from the Director: Biofire Respiratory 2.1 Panel helps tackle infections during pandemic
Respiratory tract infection is one of the most frequent and fatal infections in the geriatric population. Long-term Care Facilities (LTCF) residents are prone to infection because of the decrease in their immunity, their impaired cognitive function, frailty, congregated setting,
Letter from the Director: Reticulocyte Comprehensive Panel assists in assessing red blood cell production
Published December 2020 as part of Aculabs’ LabTalk quarterly newsletter. Aculabs will be offering a Reticulocyte Comprehensive Panel – the panel can provide comprehensive information needed by physicians to assess the rate of red cell production and hemoglobinization. Reticulocyte count
Letter from the Director: Understanding Antibody Testing Provided by Aculabs
Antibodies are proteins produced by the immune system in response to infection, often within the first week of post-symptoms onset. There are several forms of antibodies: IgG, IgM, IgA, as well as other forms. However, not all antibodies are
Letter from the Director: Biotin Influence on Laboratory Immunoassay Tests
Published September 2018 as part of Aculabs' LabTalk quarterly newsletter. Laboratory errors have been reported to be 0.012-0.6%; errors due to interference are less than 0.078%. One of the causes of interference in a laboratory is Biotin. - National
Letter from the Director: Postural Pseudoanemia in Long-Term Care Facilities
Published July 2018 as part of Aculabs' LabTalk quarterly newsletter. Anemia is very common in the geriatric population; several studies have shown that the prevalence of anemia increases with advancing in age, the increase start at the age of 65
Letter from the Director: Understanding the H1N1 Virus
Originally published in LabTalk (Volume 4, Issue 3, 2009), the quarterly newsletter of Aculabs. Novel H1N1 virus, known to be an influenza A-subtype, was originally referred to as “swine flu” because it is very similar to influenza viruses normally occurring
Letter from the Director: Accurate Diagnosis Benefits of 25-Hydroxyvitamin D
Originally published in LabTalk (Volume 4, Issue 2, 2009), the quarterly newsletter of Aculabs. Vitamin D has been well known for its role in bone metabolism; however, the important role of vitamin D beyond that was the discovery of the
Letter from the Director: High Sensitivity C-Reactive Protein & Statin Treatments
Originally published in LabTalk (Volume 4, Issue 1, 2009), the quarterly newsletter of Aculabs. JUPITER (Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin), a study published in the Nov. 20 edition of New England
Letter from the Director: Prostate Cancer Awareness & Diagnosis
Originally published in LabTalk (Volume 3, Issue 4, 2008), the quarterly newsletter of Aculabs. September was “National Prostate Cancer Awareness Month.” The goal of this annual event is to generate widespread awareness regarding prostate cancer and to give the public
Letter from the Director: Prothrombin Time Tests & Blood Clotting
Originally published in LabTalk (Volume 3, Issue 3, 2008), the quarterly newsletter of Aculabs. Prothrombin time (PT) tests measure clotting time in a blood sample from the activation of factor VII through the formation of fibrin clot. PT evaluates the
Letter from the Director: Urinary Tract Infection in Geriatric Populations
Originally published in LabTalk (Volume 3, Issue 2, 2008), the quarterly newsletter of Aculabs. Background Since UTI is very common among the geriatric population and can cause serious complications, urinalysis and urine cultures contribute vital information regarding a patient’s state
Letter from the Director: Diabetes and the Hemoglobin A1C
Originally published in LabTalk (Volume 3, Issue 1, 2008), the quarterly newsletter of Aculabs. Diabetes is a chronic illness in which the body does not properly use or produce insulin; more than 7% or an estimated 20.8 million in the
Letter from the Director: Thyroid Dysfunction
Originally published in LabTalk (Volume 2, Issue 4, 2007), the quarterly newsletter of Aculabs. Thyroid dysfunction is one of the most encountered problems in clinical practice. Adequate diagnosis and management require a thorough knowledge of the change in the thyroid
Letter from the Director: Methods for Tackling Colorectal Cancer
Originally published in LabTalk (Volume 2, Issue 3, 2007), the quarterly newsletter of Aculabs. Cancer is the second-most frequent cause of death in the United States, and Colorectal Cancer (CRC) is the third most common cancer in the US and